Medicine policy

Prices, access, distribution, pharmacies, biosimilars and AMMPS: the reforms reshaping medicine policy and pharmaceutical sovereignty.

Morocco as a pharmaceutical hub

Law 27.26: Morocco’s Bid to Become a Regional Pharmaceutical Hub

5/25/2026Medicine policy

Analysis of Law 27.26 and Morocco’s ML3 ambition, covering stronger AMMPS powers, export AMMs, conditional authorizations, pharmacovigilance, inspections and regional pharmaceutical-hub positioning.

Clinical research in Morocco

Clinical Research: Morocco’s Strategic Capacity Push

5/25/2026Medicine policy

Analysis of Morocco’s clinical-research capacity push, covering the new decree, AMMPS, sponsor attractiveness, specialized skills, health data and the MAD 8 billion R&D target.

Pharmaceutical distribution in Morocco

Pharmaceutical Distribution in Morocco

5/12/2026Medicine policy

Analysis of pharmaceutical distribution in Morocco, covering pharmacy economic pressures, Competition Council recommendations, draft Law 27-26, generic substitution, digitalization and remuneration reform.

Measles

Medicine Price Reform in Morocco

4/7/2026Medicine policy

Analysis of Morocco’s medicine price reform, between the end of stair-step pricing, maximum reference prices, industrial predictability, access and AMO balance.

Measles

Opening Pharmacy Capital in Morocco

3/17/2026Medicine policy

Analysis of Morocco’s plan to open pharmacy capital, between pressure on the community-pharmacy model, AMO reimbursements, Competition Council recommendations, sector modernization and ethical safeguards.

Chapter 30 pharmaceutical customs revision

Analysis of the Chapter 30 Revision

11/11/2025Medicine policy

Analysis of the revision of Chapter 30 of Morocco’s pharmaceutical customs nomenclature, covering import duties, local production, medicine access and health sovereignty.